Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N O'Neill

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
International Journal of Molecular Sciences|November 27, 2024
Synovial Fluid Immune Cell Composition Following Intraarticular Fracture May Contribute to Posttraumatic OsteoarthritisAlexandra Hunter Aitchison, Nicholas B Allen, Conor N O'Neill, et al.
Journal of Neurology|October 22, 2010
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosisD G MacManus, D H Miller, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2011
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b studyLudwig Kappos, Ralf Gold, David H Miller, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 21, 2024
Health care utilization and the associated costs attributable to cardiovascular disease in Ireland: a cross-sectional studyDanko Stamenic, Anthony P Fitzgerald, Katarzyna A Gajewska, et al.
Lancet (London, England)|October 31, 2008
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb studyLudwig Kappos, Ralf Gold, David H Miller, et al.
Orphanet Journal of Rare Diseases|February 9, 2019
The patient's view on rare disease trial design - a qualitative studyC M W Gaasterland, M C Jansen- van der Weide, M J du Prie-Olthof, et al.
Communications Biology|April 11, 2026
Orientia tsutsugamushi targets lamin A using Ank effectors and alters chromatin to inhibit NF-κBThomas E Siff, Paige E Allen, Haley E Adcox, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
An adaptable, reusable, and light implant for chronic Neuropixels probesC Bimbard, F Takács, J A Catarino, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
International Journal of Molecular Sciences|November 27, 2024
Synovial Fluid Immune Cell Composition Following Intraarticular Fracture May Contribute to Posttraumatic OsteoarthritisAlexandra Hunter Aitchison, Nicholas B Allen, Conor N O'Neill, et al.
Journal of Neurology|October 22, 2010
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosisD G MacManus, D H Miller, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2011
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b studyLudwig Kappos, Ralf Gold, David H Miller, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 21, 2024
Health care utilization and the associated costs attributable to cardiovascular disease in Ireland: a cross-sectional studyDanko Stamenic, Anthony P Fitzgerald, Katarzyna A Gajewska, et al.
Lancet (London, England)|October 31, 2008
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb studyLudwig Kappos, Ralf Gold, David H Miller, et al.
Orphanet Journal of Rare Diseases|February 9, 2019
The patient's view on rare disease trial design - a qualitative studyC M W Gaasterland, M C Jansen- van der Weide, M J du Prie-Olthof, et al.
Communications Biology|April 11, 2026
Orientia tsutsugamushi targets lamin A using Ank effectors and alters chromatin to inhibit NF-κBThomas E Siff, Paige E Allen, Haley E Adcox, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
An adaptable, reusable, and light implant for chronic Neuropixels probesC Bimbard, F Takács, J A Catarino, et al.
Pageof 11